Monument Therapeutics announces the grant of U.S. patent supporting MT1988 program for schizophrenia 4 Jan Written By Charlotte Kirby Charlotte Kirby
Monument Therapeutics announces the grant of U.S. patent supporting MT1988 program for schizophrenia 4 Jan Written By Charlotte Kirby Charlotte Kirby